Low-affinity NMDA receptor antagonists. The neuroprotective potential of ARL 15896AR.
Palmer
G C
GC
Biology Department, Astra Arcus USA, Rochester, New York 14602, USA. eugene.palmer@arcus.us.astra.com
Miller
J A
JA
Cregan
E F
EF
Gendron
P
P
Peeling
J
J
D000818:Animals; D002415:Cats; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D002534:Hypoxia, Brain / Q000503:physiopathology / Q000517:prevention & control; D002546:Ischemic Attack, Transient / Q000503:physiopathology / Q000517:prevention & control*; D051379:Mice; D018696:Neuroprotective Agents / Q000494:pharmacology*; D015221:Potassium Channels / Q000502:physiology; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D015222:Sodium Channels / Q000502:physiology
D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D015221:Potassium Channels; D011725:Pyridines; D016194:Receptors, N-Methyl-D-Aspartate; D015222:Sodium Channels; C096406:alpha-phenyl-2-pyridineethanamine dihydrochloride